• USP7–PKM2 Axis Regulates Macrophage Metabolism in Pancreatit

  2026-06-03

  The referenced study elucidates how ubiquitin-specific protease 7 (USP7) drives pro-inflammatory macrophage polarization in severe acute pancreatitis by modulating PKM2-dependent metabolic reprogramming. These findings offer mechanistic insight into SAP pathogenesis and suggest that targeting the USP7–PKM2 axis may provide new therapeutic avenues for controlling inflammation.

• Tigecycline in the Era of Plasmid-Borne Resistance: Deep Div

  2026-06-02

  Explore how Tigecycline, a pioneering glycylcycline antibiotic, addresses the evolving challenge of plasmid-mediated multidrug resistance. This article uniquely analyzes Tigecycline’s scientific rationale for research against carbapenem-resistant Enterobacter cloacae and informs experimental design.

• Imidazoline Antagonists Increase Insulin by Blocking K+ Chan

  2026-06-02

  This study demonstrates that imidazoline antagonists of α2-adrenoceptors, such as phentolamine, enhance insulin release by inhibiting ATP-sensitive potassium channels in pancreatic β-cells, rather than solely through adrenergic receptor blockade. The findings clarify mechanistic pathways underlying insulin secretion and have significant implications for diabetes research and K+ channel pharmacology.

• Annexin V-FITC/PI Apoptosis Assay Kit: Applied Workflows & A

  2026-06-01

  The Annexin V-FITC/PI Apoptosis Assay Kit streamlines early and late apoptosis detection with rapid, one-step staining, enabling high-resolution discrimination in complex models ranging from drug-induced liver injury to cancer research. This guide delivers actionable protocol enhancements, troubleshooting strategies, and unique translational insights from recent mitochondrial apoptosis studies.

• Optimizing Bacterial Viability Assays with Live-Dead Stainin

  2026-06-01

  Explore advanced protocols and assay insights for the Live-Dead Bacterial Staining Kit in bacterial viability research. This article reveals the scientific rationale, practical workflow enhancements, and innovative applications that set this kit apart.

• Imidazoline Antagonists Stimulate Insulin by K+ Channel Bloc

  2026-05-31

  The reference study demonstrates that imidazoline antagonists of α2-adrenoceptors increase insulin release from pancreatic β-cells in vitro by directly inhibiting ATP-sensitive potassium (K+) channels, rather than via adrenoceptor blockade. This finding clarifies drug mechanisms impacting insulin secretion and guides researchers in dissecting ion channel contributions to β-cell physiology.

• NLRP10 Regulates Keratinocyte Survival and Skin Barrier in A

  2026-05-30

  This study establishes NLRP10 as a critical regulator of epidermal homeostasis in the context of atopic dermatitis (AD), demonstrating its essential role in keratinocyte survival and differentiation via p63 stabilization. These mechanistic insights provide a foundation for targeted interventions aimed at restoring skin barrier integrity in AD.

• BMN 673 (Talazoparib): Precision Targeting of DNA Repair Def

  2026-05-29

  Explore the advanced mechanism and unique assay implications of BMN 673 (Talazoparib) as a potent PARP1/2 inhibitor in DNA repair deficiency targeting. Discover how recent insights reshape the landscape for homologous recombination deficient cancer research.

• PA-824: Optimizing Bicyclic Nitroimidazole Use in TB Researc

  2026-05-29

  PA-824 is a high-purity bicyclic nitroimidazole derivative that revolutionizes tuberculosis research by targeting both cell-wall synthesis and energy metabolism in Mycobacterium tuberculosis. This guide delivers experimental workflow enhancements, troubleshooting strategies, and protocol parameters tailored for reliable, reproducible results.

• Imidazoline Antagonists Elevate Insulin by K+ Channel Blocka

  2026-05-28

  This study demonstrates that imidazoline antagonists of α2-adrenoceptors enhance insulin secretion in vitro by inhibiting ATP-sensitive potassium channels in pancreatic β-cells, independent of adrenoceptor interaction. These findings clarify the mechanistic basis for insulinotropic effects and provide methodological guidance for ion channel and metabolic research.

• AO/PI Double Staining: A New Era for Translational Cell Deat

  2026-05-28

  Explore how the AO/PI Double Staining Kit from APExBIO empowers translational researchers to dissect cell death mechanisms with unprecedented clarity, bridging mechanistic insight and workflow strategy. Drawing on recent melanoma research and advanced cell models, this thought-leadership article goes beyond conventional product pages to chart a strategic path from biological rationale to clinical relevance.

• IRF4-Mediated B Cell Activation in ESCC: TLS and TRAF2 Dynam

  2026-05-27

  Zheng et al. reveal that tertiary lymphoid structures (TLS) rich in IRF4+ B cells independently predict favorable survival in esophageal squamous cell carcinoma (ESCC). The study uncovers a competitive interaction between CD40 and STING for TRAF2 binding, which drives IRF4-mediated B cell activation through non-canonical NF-κB signaling, illuminating new avenues for biomarker and therapeutic development.

• ARID1A-Driven Resistance Networks in Melanoma Drug Response

  2026-05-27

  This study uses integrative multi-omics to unravel how loss of ARID1A in melanoma reprograms signaling and gene expression, driving resistance to BRAF/MAPK inhibitors. The findings identify actionable resistance nodes and provide a framework for more durable therapeutic strategies.

• Cell Counting Kit-8 (CCK-8) Plus: Practical Assay Guidance

  2026-05-26

  Cell Counting Kit-8 (CCK-8) Plus enables accurate, sensitive cell proliferation and cytotoxicity quantification, streamlining workflows for drug screening and dehydrogenase activity measurement. It is ideal for applications needing rapid, WST-8 based cell viability assessment in multiwell formats, but should not be used where direct mechanistic or single-cell resolution is required.

• Structure-Based Discovery of NSP15 Inhibitors Against SARS-C

  2026-05-26

  This study applies virtual screening and molecular dynamics to identify natural product inhibitors of SARS-CoV-2 NSP15, highlighting thymopentin and oleuropein as potent candidates. The findings illuminate new directions for antiviral drug discovery by targeting viral immune evasion mechanisms.

15621 records 1/1042 page Next 12345 下5页 Last page